Touchstone International Medical Science Co Ltd (688013) — Capital Reinvestment Ratio
Touchstone International Medical Science Co Ltd (688013) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥27.05 Million) in capital expenditures (CN¥8.28 Million). See Touchstone International Medical Science free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Touchstone International Medical Science Co Ltd Capital Reinvestment Ratio (2017–2024)
This chart tracks Touchstone International Medical Science Co Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Touchstone International Medical Science Co Ltd (2017–2024)
Year-by-year Capital Reinvestment Ratio for Touchstone International Medical Science Co Ltd from 2017 to 2024. For live market cap and broader valuation context, see Touchstone International Medical Science market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | CN¥53.41 Million | CN¥41.94 Million | ▲ +253.8% |
| 2023 | 0.22x | CN¥82.95 Million | CN¥18.41 Million | ▼ -76.5% |
| 2022 | 0.95x | CN¥50.40 Million | CN¥47.67 Million | ▲ +526.2% |
| 2021 | 0.15x | CN¥60.98 Million | CN¥9.21 Million | ▼ -12.9% |
| 2020 | 0.17x | CN¥42.08 Million | CN¥7.29 Million | ▼ -35.9% |
| 2019 | 0.27x | CN¥34.82 Million | CN¥9.41 Million | ▼ -55.2% |
| 2018 | 0.60x | CN¥34.44 Million | CN¥20.78 Million | ▼ -68.7% |
| 2017 | 1.93x | CN¥7.88 Million | CN¥15.21 Million | — |